United StatesDOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2 mg/mL) 25 mL single-dose vials (NDC 72603-200-01), lot HAG2581B, exp 05/31/2027, manufactured by Sun Pharmaceutical Ind. Ltd. for Northstar Rx LLC, is being recalled nationwide in the U.S.; 675 vials were included. The recall was initiated because glass particulate matter was identified in the product.
What's being recalled
DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol, Gujarat, India, NDC 72603-200-01.
Recalling firm: Sun Pharmaceutical Industries Inc, Princeton, NJ, United States.
How to identify it
Lot HAG2581B, expires: 05/31/2027
The hazard
Presence of Particulate matter: Particulate matter identified as glass.
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
U.S. Nationwide
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)